Dr. Şahin and Dr. Türeci, who teamed up with Pfizer early in the COVID-19 pandemic to develop an mRNA-based vaccine, have been researching cancer treatments for 30 years. Dr. Şahin said cancer vaccines will be ready “before 2030.”
“We feel a cure for cancer or to changing cancer patients’ lives is in our grasp,” Dr. Türeci told the BBC. “As scientists, we are always hesitant to say, ‘We will have a cure for cancer.’ We have a number of breakthroughs and we will continue to work on them.”
This follows the rough timeline other researchers have pointed to as other drugmakers are ramping up efforts to develop a cancer vaccine. On Oct. 12, Moderna and Merck said they are partnering under a $250 million agreement to develop, manufacture and sell personalized cancer vaccine candidates.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
